Aug 2026
The miR-338-5p/METTL3 axis regulates m6A modification to inhibit tumor progression in triple-negative breast cancer.
This study reveals post-transcriptional regulation of METTL3 by miR-338-5p by confirming a functional miR-338-5p/METTL3/m6A axis in TNBC and targeting this distinct regulatory axis represents a promising therapeutic strategy for TNBC.
Wen-Jia Chen, Ya Xu, Yang-Zheng Lan et al.
· Clinical and Translational O... · 0 citations